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The cure rate of hypertension after surgery for primary aldosteronism (PA) was assessed in a single
institution. In the present study, we studied the risk factors on the cure rate of hypertension after surgery in
patients with PA. Thirty-five patients who underwent surgery for PA between January 2004 and December
2009, with a follow-up time of 1 year or longer were studied. The mean age at surgery was 50.7 years old.
The male to female ratio was 24 : 11. Factors confounding the cure rate of hypertension after surgery were
analyzed using the univariate and the multivariate analysis. Nineteen (54%) of the 35 patients were
completely cured after surgery. In most cases, a complete cure was seen within 1 month after surgery. At 1
year after surgery, the dose of medication for hypertension could be decreased in 11 (13%) of the 16 non-
cured patients. Although hypertension in patients with PA may be curable by surgery, the cure rate of
hypertension after surgery has been reported to be from 16 to 67%. In the present study, age, gender,
preoperative serum creatinine, the period of hypertension, the number of medications for hypertension, and
family history for hypertension were significant in the univariate analysis for the cure rate of hypertension
(persistent hypertension) after surgery. Multivariate analysis showed that the age of 55 years old or older
was a significant predictor for non-curable hypertension after surgery. Our result suggests that earlier sur-
gery may contribute to a better outcome on the cure rate of postoperative hypertension in patients with PA.
(Hinyokika Kiyo 59 : 225-229, 2013)
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を Table 1 に示した．収縮期血圧，拡張期血圧ともに
泌尿紀要 59 : 225-229，2013年 225
Table 1. Patient’s characteristics
年齢（歳) 27-80（50.7±10.9)






(mmHg) 155±16 135±16 p＜0.001
拡張期血圧
(mmHg) 96±11 86±9 p＜0.001
PAC (pg/ml) 305.4±167.6 71.5±29.5 p＜0.001
PRA













Fig. 1. Prognosis of hypertension after adrenalectomy. A : Prognosis of hypertension. B : Duration of cure after
operation.
Table 2. Comparison of cured and non-cured cases by surgery
高血圧治癒例（19例) 高血圧非治癒例（16例)
年齢（歳) 45.7±1.2（55歳以下16例，84.2％) 56.5±7.3（55歳以下 4例，25％) p＜0.01
男女比 9 : 10 15 : 1 p＜0.01
術前血圧 (mmHg) 156±17/96±9 55±16/95±12 NS
術前血清 Cr 濃度 (mg/dl) 0.8±0.2 1.5±1.3 p＜0.05
術前血清K濃度 (mmol/l) 2.9±0.6 3.1±0.9 NS
術前 PAC (pg/ml) 334.2±193.3 271.2±128.8 NS
術後 PAC (pg/ml) 67.2±32.9 77.4±24.1 NS
術前 PRA (ng/ml/min) 0.24±0.34 0.26±0.35 NS
術後 PRA (ng/ml/min) 1.1±0.9 2.5±2.8 NS
罹病期間（年) 6.1±4.8 9.6±5.5 p＜0.05
術前降圧薬 3剤以上 6/19（32％) 13/16（81％) p＜0.001
高血圧家族歴 3/19（16％) 8/16（50％) p＜0.05











治癒群で術前血清クレアチニン濃度が 1.46 mg/dl と，
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Table 3. Multivariate cox regression analysis for
medication-free on postoperative persis-
tent hypertension
HR (95％ CI) P value
女性 20.9（0.6-695.9) NS
年齢＜55歳 16.4（1.2-219.8) 0.035
術前 Cr 濃度 0.3（0.0-19.7) NS
罹病期間 1.2（0.9-1.6) NS




























腎腺腫（以下，APA) による PA では，副腎摘除術に





いて退院前67例， 6カ月以内52例， 1年以内15例， 1
年以上13例と報告している．また，田中ら8)は，38例
中の治癒例28例（治癒率74％）において， 2週間以内
18例， 1カ月以内 8例， 6カ月以内 2例，以降なし
と報告している．自験例では，35例中の治癒例19例
（治癒率54％）において， 2週間以内16例， 6カ月以
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Table 4. Frequency and risk factors of postop-
erative persistent hypertension in patients
with primary aldosteronism
報告者 持続性高血圧の頻度（％） 危険因子
Obara, et al. 38 年齢，性別，病理所見
Proye, et al. 44
年齢，家族歴，高血圧罹
病期間
Sawka, et al. 67
高血圧家族歴，術前降圧
剤 3剤以上
Sywak, et al. 16 解析なし
Fukudome, et al. 57 術前クレアチニン値
Lumachi, et al. 28 年齢，高血圧罹病期間





















































1) Hiramatsu K, Yamada T, Yukimura Y, et al. : A
screening test to aldosterone-producing adenoma by
measuring plasma rennin activity. results in hyper-
tensive patients. Arch Intern Med 141 : 1589-1593,
1981
2) Williams JS, Williams GH, Raji A, et al. : Prevalence of
primary hyperaldosteronism in mild to moderate
hypertension without hypokalaemia. J Hum Hyper-
tension 20 : 129-136, 2006
3) Nishikawa T and Omura M : Clinical characteristics of
primary aldosteronism : its prevalence and compar-
ative studies on various causes of primary aldoste-
ronism in Yokohama Rosai Hospital. Biomed Phar-
macother 54 : 83s-85s, 2000
4) Stowasser M and Gordon RD : Primary aldoste-
ronism-careful investigation is essential and rewarding.
Mol Cell Endocrinol 217 : 33-39, 2004
5) Gordon RD : Primary aldosteronism. J Endocrinol
Invest 18 : 495, 1995
Rocha R and Funder JW : The pathophysiology of
aldosterone in the cardiovascular system. Ann NY
Acad Sci 970 : 89-100, 2002
6) 飯原雅季，鈴木留美，川真田明子，ほか : 原発性
アルドステロン症手術症例の臨床所見と治療成
績．内分泌外科 22 : 159-164，2005




8) 田辺昌代，成瀬光栄，立木美香，ほか : 原発性ア
ルドステロン症の心血管系合併症 : 東京女子医科
大学における171例の解析と臨床的示唆，日内分
泌会誌 81 : 20-23，2005
9) Obara T, Ito Y, Okamoto T, et al. : Risk factors
associated with postoperative persistent hypertension
泌尿紀要 59巻 4号 2013年228
in patients with primary aldosteronism. Surgery 112 :
987-993, 1992
10) Proye CA, Mulliez EA, Carnaille BM, et al. : Essential
hypertension : first reason for persistent hypertension
after unilateral adrenalectomy for primary aldoste-
ronism ? Surgery 124 : 1128-1133, 1998
11) Sawka AM, Young WF Jr, Thompson GB, et al. :
Primary aldosteronism : factors associated with nor-
malization of blood pressure after surgery. Ann In-
tern Med 135 : 258-261, 2001
12) Sywak M and Pasieka JL : Long-term follow-up and
cost benefit of adrenalectomy in patients with primary
hyperaldosteronism. Br J Surg 89 : 1587-1593, 2002
13) Fukudome Y, Fujii K, Arima H, et al. : Discriminating
factors for recurrent hypertension in primary aldoste-
ronism after adrenalectomy. Hypertens Res 25 : 11-
18, 2002
14) Lumachi F, Ermani M, Basso SM, et al. : Long term
results of adrenalectomy in patients with aldosterone-
producing adenomas : multivariate analysis of factors
affecting unresolved hypertension and review of the
literature. Am Surg 71 : 864-869, 2005
15) Meyer A, Brabant G and Behrend M : Long-term
follow-up after adrenalectomy for primary aldoste-
ronism. World J Surg 29 : 155-159, 2005
16) Sechi LA, Novello M, Lapenna R, et al. : Long-term
renal outcomes in patients with primary aldosteronism.
JAMA 295 : 2638-2645, 2006
(Accepted on November 6, 2012)
Received on August 27, 2012
古田，ほか : 高血圧・原発性アルドステロン症 229
